telt 10 nieuwe leden








De 10 nieuwe leden voor zijn het bewijs van de aantrekkelijkheid van de Belgische biofarmaceutische sector. Het zijn bedrijven die ofwel opgestart zijn in België, of die beslist hebben om zich hier te vestigen om actief deel te nemen aan de dynamiek van ons biofarmaceutisch ecosysteem.

Hierbij een oplijsting van de nieuwe leden met een link naar hun activiteiten:

PTC Therapeutics International : At PTC, we are focused on modulating protein expression within the cell. We have developed and assembled an integrated set of proprietary technologies focused on our understanding of RNA biology for the discovery of novel small molecule therapeutics. Our technologies allow us to screen our compound library against targets across multiple therapeutic areas

Clovis Oncology France : Innovating cancer drugs through precision medicine. We are a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.

Alnylam Netherlands : Science That Can Change the World. The discovery of RNA interference (RNAi) has been heralded as a major scientific breakthrough of the kind that happens only once every decade or so, and it represents one of the most promising and rapidly advancing frontiers in biology and drug discovery today. With investigational RNAi therapeutics, it is possible to block the production of disease-causing proteins.

Sigma-tau Pharma Belgium : The latest sigma-tau research has focused on a number of main lines. On the one hand, there is the pharmaco-biological study of carnitines, substances of natural origin particularly adapted to correct the biochemical and metabolic defects responsible for many diseases. A second aspect concerns the company's commitment in the therapeutic areas in which it has specific know-how and / or a consolidated presence in the field of metabolic diseases, infectiology and immunology. The third major point is the work done in the field of onco-hematology, and autoimmune diseases, which include major therapeutic indications

Promethera Biosciences : Global Innovator in Liver Disease Therapeutics. Promethera’s mission is to apply its proprietary liver cell-based technology to meet the needs of patients with acute and chronic liver diseases.

Tesaro Bio France : TESARO Bio France SAS's mission is to provide cancer patients with innovative health products.

Vifor Fresenius Medical Care Renal Pharma Belgique : Vifor Pharma Group, formerly Galenica Group, is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.

Novadip Biosciences : A biomedical spin-off for regenerative medicine, in full expansion. While Novadip’s first mission was to treat patients with bone defects and bone diseases, its innovative adipose stem cell-based technology offers potential for further applications, including skin regeneration. These therapies solve real problems faced by doctors and patients around the world, and are aimed at more positive clinical outcomes and long-term quality of life.

Serb : SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs. Our commitment is to continue to offer essential drugs meeting Public Health needs.

Celyad : Celyad is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.

 Link naar alle leden van